Navigation Links
New twist on old medical technology may prevent amputations
Date:1/27/2009

Old technologies, bone cement and a well known antibiotic, may effectively fight an emerging infection in soldiers with compound bone fractures, according to a study published online today in the Journal of Orthopedic Research. An urgent search for solutions is underway as 20,000 additional American soldiers head for Afghanistan, and as evidence emerges that the infection studied may set the stage for more dangerous infections that can lead to amputation.

Osteomyelitis is (OM) a bone infection caused by various bacteria, and usually occurs in severe fractures when bone is exposed to open air. Although Acinetobacter baumannii rarely causes OM in the United States, it is very prevalent in the Middle East, and is now present in more than 30 percent of soldiers recovering from open fractures in field hospitals in Iraq and Afghanistan. Past studies have established that one in four severe war wounds in Iraq is a fracture, more than 80 percent of which are open, where the bone is exposed to airborne bacteria.

Not common in the United States and not potentially fatal, A. baumannii OM had been largely ignored until recently by physicians and the pharmaceutical industry, which focuses on life-threatening infections that affect millions, not hundreds. Then military outbreaks of the infection started among American soldiers returning from Iraq in 2003, with the number of A. baumannii OM infections seen in field hospitals, and in stateside facilities receiving injured soldiers, growing. At the same time, data began to emerge from hospitals treating soldiers suggesting that easily contracted A. baumannii may be arriving first at the fracture site and "priming" it so that it becomes more vulnerable to methicillin-resistant Staphylococcus aureus (MRSA), which recently surpassed HIV as the most deadly pathogen in the United States despite nearly universal use of the best available antibiotics.

"If you apply the findings from two small studies
'/>"/>

Contact: Greg Williams
Greg_Williams@urmc.rochester.edu
585-273-1757
University of Rochester Medical Center
Source:Eurekalert

Page: 1 2 3 4

Related medicine news :

1. New Twist on Treatment of Foot Pain
2. Holiday Meals With a Calorie-Conscious Twist
3. Jennifer & Gigi: A Story of Love and Compassion with a Hollywood Twist -- In honor of National Family Caregivers Month, CarePages.com celebrates "Grandma Gene" and gives a voice to the community of caregivers around the world
4. Video: 2008 US Olympic Gymnastic Superstars Join Todays Top Music Icons for Womens Cancer Awareness Network Special, Frosted Pink with a Twist
5. Direct From Beijing, 2008 Olympic Gymnastic Superstars and Grammy Award Winning Icons Descend Upon San Diego to Tape ABC Network Womens Cancer Awareness Special, Frosted Pink With A Twist
6. Bright Starts(TM) Adds New Twist to Old Favorites
7. Olympic Champion Mary Lou Retton and ASCO Join Frosted Pink with a Twist to Empower Women Through Education and Advocacy
8. V8 V-Fusion(R) Takes an Exotic, Tasty Twist on Vegetable Juice
9. DNA with a twist: New company to search for cancer drugs and antibiotics
10. FDA Approves ASMANEX (R) TWISTHALER(R) (Mometasone Furoate Inhalation Powder) for the Once Daily Maintenance Treatment of Asthma in Children Ages 4-11
11. DC Ranch Village Health Club & Spa Twists with Chocolate Yoga Class
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/28/2015)... ... August 28, 2015 , ... Northridge dentists Dr. Elyson and ... just $199, patients can currently receive a one hour treatment of this teeth whitening ... it includes a number of unique features that can turn teeth up to nine ...
(Date:8/28/2015)... , ... August 28, 2015 , ... ... announce its collaboration with coffee connoisseur and Emmy-nominated actress, Sofia Vergara, and unveil ... features revolutionary Thermal Flavor Extraction™ technology, which delivers a variety of sizes and ...
(Date:8/28/2015)... ... August 28, 2015 , ... ... to distributing health information technology innovation to transform quality and efficiency of healthcare ... survey will be de-identified and aggregated before being publicly shared to document progress ...
(Date:8/28/2015)... DC (PRWEB) , ... August ... ... Information Services, Inc.’s (AIS) Medicare-Medicaid Dual Eligibles Database have added comprehensive information ... CMS-backed alignment demonstration approved for a December 2015 launch; and Idaho’s partnership ...
(Date:8/28/2015)... ... August 28, 2015 , ... Popular review site ... millionaire dating sites . According to the listings, MillionaireMatch.com bags the ... category. , A spokesperson of Top5MillionaireDatingSites.com said, “This website has been ...
Breaking Medicine News(10 mins):Health News:Northridge Dentists Dr. Elyson and Dr. Assili Now Offer a Special Promotion on Zoom Teeth Whitening 2Health News:Sofia Vergara Partners With SharkNinja® To Launch The Ninja Coffee Bar™ 2Health News:Sofia Vergara Partners With SharkNinja® To Launch The Ninja Coffee Bar™ 3Health News:WEDI's The Sullivan Institute for Healthcare Innovation Releases Gaps in Care Survey 2Health News:AIS Duals Database: August Update Finds Two New Duals Programs in Rhode Island and Idaho 2Health News:Top5MillionaireDatingSites.com Publishes Its First List of Reviews of the Best Millionaire Dating Sites 2
... TeamStaff, Inc.,(Nasdaq: TSTF ) a national provider of ... notified by the Nasdaq Stock,Market that the Nasdaq Hearings ... the Nasdaq Global Market pending the effectiveness of the,Company,s ... was held on February 7, 2008. The decision of ...
... mg Delivers the Same, Medicine at the Same Dose ... Nearly 30 Million Frequent ... Beginning early March 2008,the nearly 30 million frequent heartburn ... them as retailers begin selling store,brand Omeprazole, a proton ...
... CHAPEL HILL, N.C., March 12 R&D structure ... is,essential to pharmaceutical companies. In a competitive market ... process increases -- the need to have an,optimized ... Discover the best-suited organizational structure that promotes rapid,growth, ...
... Calif., March 12 Omnicell,Inc. (Nasdaq: OMCL ), ... announced today that it has completed its $40.0,million program ... of,2,133,898 shares were repurchased at an average price of ... OMCL ) is a leading provider of systems and,software ...
... part of its ongoing effort to,give consumers information ... announced that four area hospitals have been,selected as ... Blue Distinction(R) is a nationwide program created ... care decisions and to work with their,health care ...
... Plans Participation in 2009 Medicare Advantage Open Enrollment in ... Florida Upon Approval of Applications, ... (Pink Sheets: PHYH), a developer of,health maintenance organizations (HMOs) in ... applications for the launch,of its pilot HMO in the state ...
Cached Medicine News:Health News:Nasdaq Hearings Panel Grants TeamStaff's Request for Continued Listing Subject to a Reverse Stock Split 2Health News:Nasdaq Hearings Panel Grants TeamStaff's Request for Continued Listing Subject to a Reverse Stock Split 3Health News:First Over-The-Counter Store Brand Omeprazole Offering in U.S. Market Creates New Option for Frequent Heartburn Sufferers 2Health News:First Over-The-Counter Store Brand Omeprazole Offering in U.S. Market Creates New Option for Frequent Heartburn Sufferers 3Health News:R&D Quality Excellence: Proven Tactics Optimize the R&D Quality Organizations of Pharmaceutical and Biotech Industries 2Health News:Omnicell Announces Completion of Its Common Stock Repurchase Plan 2Health News:Independence Blue Cross Announces Blue Distinction Centers for Complex and Rare Cancers(SM) in Philadelphia 2Health News:Independence Blue Cross Announces Blue Distinction Centers for Complex and Rare Cancers(SM) in Philadelphia 3Health News:Phyhealth Submits HMO Applications with Required Federal and State Agencies 2Health News:Phyhealth Submits HMO Applications with Required Federal and State Agencies 3
(Date:8/28/2015)... 2015 According to a new ... Lung, Prostate) Type (Protein & Genetic Biomarkers) Profiling Technology ... & Geography - Global Forecast to 2020", published by ... around 17,689.0 Million USD by 2020 at a CAGR ... 2020. Browse 191 Tables and 38 ...
(Date:8/28/2015)... 28, 2015 Research ... addition of the "Investigation Report on China,s ... Originally discovered by Welfide (Mitsubishi Tanabe ... Ltd) as an inflammatory drug, pranoprofen was later ... Ltd under the trade name of pranopulin for ...
(Date:8/28/2015)... DUBLIN , Aug. 28, 2015 ... announced the addition of the "Investigation Report on ... Developed by Roche under the trade name ... in the world. In Feb.26, 2010, it was approved ... injections available in China all ...
Breaking Medicine Technology:Cancer Biomarkers Market Worth 17,689.0 Million USD by 2020 2Cancer Biomarkers Market Worth 17,689.0 Million USD by 2020 3Cancer Biomarkers Market Worth 17,689.0 Million USD by 2020 4Cancer Biomarkers Market Worth 17,689.0 Million USD by 2020 5Investigation Report on China's Pranoprofen Market, 2010-2019 2Investigation Report on China's Bevacizumab Market 2015-2019 2
... from Serial Outpatient Infusion Study in Patients with,Chronic ... Cardiology 56th Annual Scientific Session --, MOUNTAIN VIEW, ... Scios Inc. announced today that an exploratory,920-patient, Phase ... on the primary endpoint, a composite of death ...
... March 25, 2007 /PRNewswire/ -- Once-daily,dosing with ... antagonist, was associated with improvements,in signs and ... hospitalized patients receiving conventional care, without an,adverse ... These,data are from the short- and long-term ...
Cached Medicine Technology:Scios Announces Results From Exploratory Nesiritide Study Providing,Important New Renal and Mortality Safety Data with a Neutral Effect,on the Primary Endpoint 2Scios Announces Results From Exploratory Nesiritide Study Providing,Important New Renal and Mortality Safety Data with a Neutral Effect,on the Primary Endpoint 3Scios Announces Results From Exploratory Nesiritide Study Providing,Important New Renal and Mortality Safety Data with a Neutral Effect,on the Primary Endpoint 4Scios Announces Results From Exploratory Nesiritide Study Providing,Important New Renal and Mortality Safety Data with a Neutral Effect,on the Primary Endpoint 5Scios Announces Results From Exploratory Nesiritide Study Providing,Important New Renal and Mortality Safety Data with a Neutral Effect,on the Primary Endpoint 6Scios Announces Results From Exploratory Nesiritide Study Providing,Important New Renal and Mortality Safety Data with a Neutral Effect,on the Primary Endpoint 7Everest Data on Short- and Long-Term Use of Otsuka's,Investigational Novel Treatment, Tolvaptan, Published in Journal of,the American Medical Association and Featured in ACC's Late,Breaking Clinical Trials 2Everest Data on Short- and Long-Term Use of Otsuka's,Investigational Novel Treatment, Tolvaptan, Published in Journal of,the American Medical Association and Featured in ACC's Late,Breaking Clinical Trials 3Everest Data on Short- and Long-Term Use of Otsuka's,Investigational Novel Treatment, Tolvaptan, Published in Journal of,the American Medical Association and Featured in ACC's Late,Breaking Clinical Trials 4Everest Data on Short- and Long-Term Use of Otsuka's,Investigational Novel Treatment, Tolvaptan, Published in Journal of,the American Medical Association and Featured in ACC's Late,Breaking Clinical Trials 5Everest Data on Short- and Long-Term Use of Otsuka's,Investigational Novel Treatment, Tolvaptan, Published in Journal of,the American Medical Association and Featured in ACC's Late,Breaking Clinical Trials 6Everest Data on Short- and Long-Term Use of Otsuka's,Investigational Novel Treatment, Tolvaptan, Published in Journal of,the American Medical Association and Featured in ACC's Late,Breaking Clinical Trials 7
Resorbable fixation system 1.5/2.0....
... By combining intra-operative ... imagery, Medtronic Surgical Navigation ... revolutionary product called SonoNav ... system built on the ...
... the two steps are performed in sequence ... single use disposable cartridge and placed in ... touches a button, and the cycle begins. ... Then the integral syringe pump concentrates fibrinogen, ...
Avitene Microfibrillar Collagen Hemostat (MCH) is used in surgical procedures as an adjunct to hemostasis when control of bleeding by ligature or conventional procedures is ineffective or impractical...
Medicine Products: